The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian As unregulated peptides grow in popularity, doctors warn of unknown risks ABC11 Raleigh Durham